Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy.
about
Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired WeaknessArgument against the Routine Use of Steroids for Pediatric Acute Respiratory Distress SyndromeRationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach UsPulmonary epithelial barrier function: some new players and mechanismsThe acute respiratory distress syndrome: from mechanism to translationCorticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland.Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis.Rapid induction of autoantibodies during ARDS and septic shock.Acute respiratory distress syndrome: pathophysiology and therapeutic optionsFibroproliferative changes on high-resolution CT in the acute respiratory distress syndrome predict mortality and ventilator dependency: a prospective observational cohort study.Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness.Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature.Molecular imaging of folate receptor β-positive macrophages during acute lung inflammation.Regulation of inflammatory biomarkers by intravenous methylprednisolone in pediatric ARDS patients: Results from a double-blind, placebo-controlled randomized pilot trial.Statins in the critically illCoagulopathy as a prognostic factor of acute lung injury in childrenIL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids.Corticosteroids and acute respiratory distress syndrome: the debate continues.Inhibition of c-Jun N-terminal Kinase Signaling Pathway Alleviates Lipopolysaccharide-induced Acute Respiratory Distress Syndrome in Rats.Omentin protects against LPS-induced ARDS through suppressing pulmonary inflammation and promoting endothelial barrier via an Akt/eNOS-dependent mechanism.Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome.Immunomodulatory therapy for severe influenza.Understanding ARDS-associated fibroproliferation.Pulmonary vascular dysfunction in ARDS.Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial.Diagnostic workup for ARDS patients.Special considerations for the management of pediatric acute respiratory distress syndrome.Preadmission Oral Corticosteroids Are Associated With Reduced Risk of Acute Respiratory Distress Syndrome in Critically Ill Adults With Sepsis.Current Concepts of ARDS: A Narrative Review.Protective effect of suppressing STAT3 activity in LPS-induced acute lung injuryAnalgesic Effect of Dexamethasone after Arthroscopic Knee Surgery: A Randomized Controlled Trial.What's new in critical illness and injury science? State of the art in management of ARDS.Regulation of S1P receptors and sphingosine kinases expression in acute pulmonary endothelial cell injuryCorticosteroids in pediatric ARDS: all cards on the table.Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia?Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement.Toward computational identification of multiscale "tipping points" in acute inflammation and multiple organ failure.Early steroid therapy for patients with H1N1 influenza A virus infection.Isoliquiritigenin Activates Nuclear Factor Erythroid-2 Related Factor 2 to Suppress the NOD-Like Receptor Protein 3 Inflammasome and Inhibits the NF-κB Pathway in Macrophages and in Acute Lung Injury.Vaspin protects against LPS‑induced ARDS by inhibiting inflammation, apoptosis and reactive oxygen species generation in pulmonary endothelial cells via the Akt/GSK‑3β pathway.
P2860
Q26741099-F74DAD1A-8C33-4ABA-82BF-BC800B43DD73Q26741709-B978490E-A131-4FB3-B3CB-688F8741C730Q26744478-6A152920-B716-4573-9B9E-EC91191E4462Q26865861-058525E6-B478-4594-B1CA-CC5F137A0777Q28386068-B7785433-DE65-4F83-BCC5-99177F2D67ACQ30409590-DCEA15B7-2447-4240-98F0-AE59FC877CF1Q33750310-0F5B6B06-EA87-4E56-BBC7-0B37412A0571Q34267557-5B0CB71B-162F-4E34-AED3-36D22FE319B5Q35757010-2232F21B-2695-4716-819A-6C5BCDB3980CQ35800565-1E154E53-6774-4187-9C12-97618AC28B78Q35806787-C660C735-A49E-4FAD-8F49-EB99E803C3DEQ35823842-86A8DAC1-4D35-49A3-B90C-07A8AD702946Q36049484-807D74DF-1CB9-44A5-A383-D7C6037E57FFQ36338911-50BEE60D-0FAF-4051-BB42-438DD342353AQ36369699-ED3C0521-099C-4F14-AFEE-8B90CEAF7693Q36472995-61CB5B1B-BB09-4351-8A5D-6BDC764C6B3BQ36916386-28F4D975-0796-4E99-9590-D43C3EE25F41Q36990299-606EA0F9-A510-49C8-9D0B-3779F939F1F4Q37126229-18E28767-0082-460F-AFFA-ED70045BB8A9Q37330863-5A167E6E-5EFD-4582-AB2C-E4134F8377C4Q37734444-FE2B0711-AEB3-419D-827A-59D1829EA10EQ37910249-7D8E3528-F0F3-47BA-9477-DDB139BB1D7EQ38310681-B319706C-778F-4738-8A6A-F25192AAA120Q38320363-C6B8BFEF-328D-4B4A-82FB-7D103634440DQ38386593-C7293945-8179-49CF-9588-902A5977812EQ38785993-C715AB53-B744-4E3D-9C4D-9EEEAEA7292CQ38921686-D80FAC05-AF7F-4FE4-9433-550846BD8BC8Q38931019-8C699EAF-BD12-469C-A3BC-FBB66E73EEC6Q39063062-44294573-49C3-4338-9774-AC23EC95793DQ40471161-49E19EC3-7A7D-4FE5-8D99-77C317C52F02Q41481702-7726A2D4-4171-445D-A85F-3817EC41DC8EQ42268914-92A57F1E-5FBB-48CC-86B0-FF3F949AC976Q42352590-4E513297-2A0B-4A41-96F6-F3E7280B6231Q43239033-C8439F0B-8DCB-4816-8B22-0A69466684DEQ44127294-2ACD456B-53DC-4760-976B-2D5542D0D167Q44657275-2182B4CF-10E9-4176-A787-C92D9D5DDF80Q44774893-2D31C53D-DCE6-41FC-B144-0543B59A0326Q45365585-8B1E6CA2-FB26-47BF-BCB9-3337D0B6D198Q46256573-EAAF6680-CB3F-4323-8494-E5B99C347639Q46283198-068D1D20-D27F-4D11-9391-EF7B8ECE1AA4
P2860
Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activation and regulation of s ...... longed glucocorticoid therapy.
@en
Activation and regulation of s ...... longed glucocorticoid therapy.
@nl
type
label
Activation and regulation of s ...... longed glucocorticoid therapy.
@en
Activation and regulation of s ...... longed glucocorticoid therapy.
@nl
prefLabel
Activation and regulation of s ...... longed glucocorticoid therapy.
@en
Activation and regulation of s ...... longed glucocorticoid therapy.
@nl
P2093
P356
P1433
P1476
Activation and regulation of s ...... longed glucocorticoid therapy.
@en
P2093
Djillali Annane
G Umberto Meduri
George P Chrousos
Scott E Sinclair
P304
P356
10.1378/CHEST.08-2408
P407
P577
2009-10-03T00:00:00Z